ArticleChildren (Basel, Switzerland)2022

Recombinant Human Growth Hormone Therapy for Childhood Trichorhinophalangeal Syndrome Type I: A Case Report.

Dan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.